Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 35.88%1.43B | 19.10%1.64B | 233.84%791.2M | -23.93%4.38B | 21.85%1.71B | 0.54%1.06B | -42.32%1.37B | -74.23%237M | 85.76%5.76B | 10.52%1.41B |
| Net profit before non-cash adjustment | 64.91%596M | -17.68%484.3M | -4.63%735.4M | -38.70%1.28B | -166.02%-437.28M | -22.21%361.4M | 73.44%588.3M | 22.86%771.1M | 11.71%2.09B | 1.85%662.32M |
| Total adjustment of non-cash items | -18.94%457.6M | 13.74%660.7M | 10.27%628.1M | 12.19%2.92B | 81.97%1.2B | -10.04%564.5M | -13.40%580.9M | -11.28%569.6M | -18.77%2.6B | -34.96%661.68M |
| -Depreciation and amortization | -10.55%481.4M | -8.51%514.7M | -11.68%493.2M | 0.16%2.16B | -14.05%501.11M | 4.44%538.2M | 5.12%562.6M | 6.71%558.4M | 4.69%2.16B | 8.97%583.05M |
| -Reversal of impairment losses recognized in profit and loss | 148.39%46.2M | 226.48%115.9M | 169.37%29.9M | 315.63%1.07B | 603.63%1.01B | -7.00%18.6M | 303.41%35.5M | -87.09%11.1M | -56.23%257.84M | -51.49%143.04M |
| -Assets reserve and write-off | ---- | ---- | ---- | -1,790.38%-239.19M | ---- | ---- | ---- | ---- | --14.15M | ---- |
| -Share of associates | -232.26%-20.6M | 67.58%-7.1M | -11.22%-10.9M | 16.05%-97.1M | -47.74%-59.2M | -342.86%-6.2M | -1,052.63%-21.9M | 86.45%-9.8M | -561.74%-115.67M | -557.90%-40.07M |
| -Disposal profit | -3,130.23%-138.9M | 114.79%5.4M | 39.46%-49.7M | -1,130.13%-174.52M | -7,732.32%-51.62M | -116.86%-4.3M | -6,183.33%-36.5M | -865.88%-82.1M | 176.66%16.94M | -107.75%-659K |
| -Net exchange gains and losses | 140.00%12.8M | -772.09%-28.9M | 125.00%2.7M | -713.58%-15.4M | 36.91%11.1M | -57.64%-32M | -73.29%4.3M | 120.69%1.2M | 78.63%-1.89M | -24.52%8.11M |
| -Other non-cash items | 52.79%76.7M | 64.50%60.7M | 79.41%162.9M | -22.08%213.31M | 177.08%35.41M | -43.21%50.2M | -67.05%36.9M | -23.89%90.8M | -51.10%273.77M | -128.82%-45.93M |
| Changes in working capital | 193.52%380.7M | 140.44%490.5M | 48.15%-572.3M | -83.35%176.59M | 1,052.02%946.59M | 407.35%129.7M | -85.12%204M | -215.34%-1.1B | 153.61%1.06B | 120.79%82.17M |
| -Change in receivables | 164.74%379.9M | 516.49%400.1M | 47.88%-216M | 218.69%505.16M | 1,424.59%711.16M | 154.15%143.5M | -90.01%64.9M | -140.65%-414.4M | 105.63%158.51M | 95.88%-53.69M |
| -Change in inventory | 24.53%6.6M | -235.71%-7.6M | 76.74%22.8M | -281.48%-16.14M | -697.86%-39.94M | 630.00%5.3M | 609.09%5.6M | -19.38%12.9M | -69.23%8.89M | -117.69%-5.01M |
| -Change in payables | 69.63%-5.8M | -32.85%78.3M | 47.56%-359.4M | -134.97%-312.43M | 303.40%275.38M | -107.89%-19.1M | -84.48%116.6M | -307.67%-685.3M | -2.85%893.36M | -92.51%68.26M |
| -Changes in other current assets | ---- | ---- | -16.57%-19.7M | ---- | ---- | -11.48%-20.4M | -24.13%-35.5M | 34.24%-16.9M | ---- | ---- |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | -138.03%-50.7M | -56.54%-33.5M | 30.92%-18.1M | -70.18%-102.33M | -23.22%-33.43M | -131.52%-21.3M | -89.38%-21.4M | -109.60%-26.2M | -6.01%-60.13M | -20.47%-27.13M |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 33.77%1.38B | 18.51%1.6B | 266.75%773.1M | -24.92%4.28B | 21.82%1.68B | -0.61%1.03B | -42.95%1.35B | -76.76%210.8M | 87.25%5.7B | 10.34%1.38B |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 96.22%-7.3M | 1.38%-815.7M | -9.08%-165.8M | 23.31%-1.77B | -46.75%-596.84M | 62.86%-193M | -238.14%-827.1M | 86.62%-152M | -15.27%-2.31B | 0.63%-406.72M |
| Net business purchase and sale | -49.90%-76.3M | 49.36%-39.6M | -309.93%-111.5M | -301.00%-171.94M | 63.52%-15.64M | ---50.9M | ---78.2M | ---27.2M | 84.85%-42.88M | ---42.88M |
| Net investment product transactions | -45.02%214.6M | 32.59%-217.8M | 80.84%-70.9M | 51.19%-37.55M | 9.98%265.25M | 307.94%390.3M | -147.78%-323.1M | ---370M | -499.94%-76.92M | 6,923.18%241.18M |
| Advance cash and loans provided to other parties | ---17.2M | ---- | ---- | --0 | --0 | --0 | ---- | ---- | ---12.3M | ---- |
| Dividends received (cash flow from investment activities) | -39.02%22.5M | -40.04%29.2M | -7.61%26.7M | 15.32%194.31M | 64.89%79.81M | -18.36%36.9M | 75.81%48.7M | -38.77%28.9M | -0.82%168.5M | -13.10%48.4M |
| Interest received (cash flow from investment activities) | -28.71%57.6M | -35.60%53.9M | -39.95%53.2M | 17.39%337.62M | -25.87%84.52M | 13.80%80.8M | 56.74%83.7M | 80.08%88.6M | 144.60%287.6M | 80.73%114M |
| Net changes in other investments | ---- | ---- | ---- | 119.01%254.93M | ---- | ---- | ---- | ---- | 237.52%116.4M | ---- |
| Investing cash flow | -26.58%193.9M | 8.87%-998.8M | 37.85%-268.3M | 36.15%-1.19B | 23.99%72.02M | 144.68%264.1M | -272.92%-1.1B | 58.46%-431.7M | 3.95%-1.87B | 110.84%58.09M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | -107.75%-17.4M | -2,472.03%-1.6B | 1,629.45%1.43B | -33.74%-1.54B | -335.40%-1.78B | 467.59%224.6M | 91.60%-62.2M | 35.69%82.5M | -587.30%-1.15B | 74.87%-409.74M |
| Increase or decrease of lease financing | -17.66%-39.3M | -56.58%-47.6M | 7.52%-28.3M | -11.66%-108.68M | -20.70%-14.28M | -133.57%-33.4M | 39.56%-30.4M | -46.41%-30.6M | 20.80%-97.33M | 53.41%-11.83M |
| Cash dividends paid | 0.00%-357.1M | 0.00%-357.1M | 0.00%-535.6M | -0.00%-1.61B | -14.31%-357.15M | 20.00%-357.1M | -14.27%-357.1M | 0.00%-535.6M | -9.09%-1.61B | -0.00%-312.45M |
| Cash dividends for minorities | --100K | ---- | ---- | --0 | --0 | --0 | --0 | --0 | ---8.04M | ---40K |
| Interest paid (cash flow from financing activities) | -21.05%-154.7M | 14.65%-196.9M | 7.38%-129.3M | -2.45%-726.86M | -1.36%-228.76M | 6.24%-127.8M | -5.83%-230.7M | -7.80%-139.6M | -30.28%-709.49M | -0.68%-225.69M |
| Net other fund-raising expenses | 302.70%97.7M | -7.33%-87.9M | 812.20%58.4M | 47.10%-183.98M | 69.75%-45.68M | -386.87%-48.2M | 27.39%-81.9M | 88.93%-8.2M | -229.88%-347.8M | -101.01%-151M |
| Financing cash flow | -37.67%-470.7M | -201.72%-2.3B | 225.42%792M | -6.25%-4.17B | -118.76%-2.43B | 48.82%-341.9M | 46.86%-762.3M | 10.72%-631.5M | -92.16%-3.92B | 51.02%-1.11B |
| Net cash flow | ||||||||||
| Beginning cash position | -12.52%4.67B | 12.02%6.57B | -18.87%5.31B | 2.17%6.55B | -12.49%5.54B | -18.48%5.34B | 5.44%5.87B | 2.17%6.55B | -8.41%6.41B | -23.90%6.33B |
| Current changes in cash | 15.71%1.11B | -235.00%-1.7B | 252.14%1.3B | -1,095.98%-1.08B | -307.72%-677.93M | 537.96%956.5M | -178.99%-506.5M | -1.54%-852.4M | 90.40%-90.33M | 121.01%326.37M |
| Effect of exchange rate changes | 93.73%-47.5M | -1,031.46%-201.4M | -120.08%-34.9M | -167.48%-154.87M | 495.22%446.63M | -22,854.55%-757.5M | -105.10%-17.8M | 6,093.10%173.8M | -34.96%229.49M | 68.72%-113.01M |
| End cash Position | 3.46%5.73B | -12.52%4.67B | 12.02%6.57B | -18.87%5.31B | -18.87%5.31B | -12.49%5.54B | -18.48%5.34B | 5.44%5.87B | 2.17%6.55B | 2.17%6.55B |
| Free cash flow | 17.98%993.6M | 49.94%786.3M | 560.42%607.3M | -22.34%2.46B | 40.09%1.23B | 62.02%842.2M | -75.30%524.4M | 62.02%-131.9M | 323.87%3.17B | 1.69%877.5M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.